Thank You to everyone who participated, donated, sponsored and/or volunteered in our
11th Annual Outpacing Melanoma 5K!

Results   Photos   Donate  

Sponsor Spotlight

Our Race and Mission would not be possible without help from our sponsors.

View All Sponsors »

Our Mission

Outpacing Melanoma is a 501(c)(3) non-profit organization dedicated to funding research for and increasing awareness of melanoma by promoting prevention, screening and early detection throughout the Kansas City region. Melanoma, the most deadly form of skin cancer, is an often-neglected disease. Outpacing Melanoma is dedicated to fighting this disease - every step of the way.

Our mission supports the Richard A. Klover Melanoma Fund, which benefits The University of Kansas Cancer Center and our local community.

Dot-to-Dot Kid Trot

Dot-to-Dot Kid Trot

A fun run is designed for kids age 10 and younger who may be too young to complete a 5K.

Register More Info

A Walk to Remember,
Our Loving Tributes

View tributes that have been shared for lost loved ones.

If you would like to honor the memory of a loved one please contact us at

View Tributes

Support Us

Proceeds from the annual Outpacing Melanoma 5K Run/Walk support melanoma research and help fund the Melanoma Survivorship Clinic at The University of Kansas Cancer Center through the Richard A. Klover Melanoma Fund.

Consistent with its mission, Outpacing Melanoma has funded and will continue to support the following efforts:

  • Prevention: In partnership with the Masonic Cancer Alliance and Kansas Cancer Partnership, Outpacing Melanoma funds Pool Cool, a sun-safety education and training program.
  • Screening: Outpacing Melanoma sponsors melanoma cancer screenings the first Monday in May - 'Melanoma Monday' - and at events across the state.
  • Survivorship: The Melanoma Survivorship Clinic was launched to address the unique challenges melanoma survivors face with ongoing care due to their increasing numbers and expanding treatment options.
  • Education: Outpacing Melanoma is funding an online program - INFORMED Skin Cancer Education Series - that allows primary care practitioners to better recognize and manage malignant melanoma.
  • Clinical Trials: A National Cancer Institute-designated Cancer Center, The University of Kansas Cancer Center offers the latest clinical trials, giving patients more options for cutting-edge care and more hope for survival. Outpacing Melanoma has funded a novel clinical trial in the use of CAR-T cell therapy to treat melanoma, and is poised to launch another third generation CAR-T study.